CUORiPS Inc. announced that it has entered into an agreement for private placements of shares for gross proceeds of ¥1.6 billion in a round of funding on March 15, 2021. The transaction included participation from JAFCO SV6 Series a fund managed by JAFCO Group Co., Ltd. (TSE : 8595), JIC Venture Growth Investments Co., Ltd., Osaka University Venture Capital Co., Ltd., Fujifilm Corporation, CellSource Co., Ltd. (TSE : 4880), Kyoto-University-Venture NVCC No.2 Investment Limited Partnership and other investors.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,422 JPY | -4.50% | -5.89% | +11.18% |
2023 | Certain Common Shares of Cuorips Inc. are subject to a Lock-Up Agreement Ending on 23-DEC-2023. | CI |
2023 | MEDERI Inc. announced that it has received funding from CellSource Co., Ltd. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.18% | 181M | |
-16.58% | 8.49B | |
+58.90% | 4.08B | |
-39.78% | 2.42B | |
-10.33% | 2.42B | |
-8.91% | 2.33B | |
-2.53% | 2.01B | |
-19.90% | 1.53B | |
-38.30% | 1.26B | |
+2.19% | 1.07B |
- Stock Market
- Equities
- 4880 Stock
- News CellSource Co., Ltd.
- Cuorips Inc. announced that it has received ¥1.6 billion in funding from JIC Venture Growth Investments Co., Ltd., JAFCO Group Co., Ltd., Osaka University Venture Capital Co., Ltd., Fujifilm Corporation, CellSource Co., Ltd., Kyoto-University-Venture NVCC No.2 Investment Limited Partnership